Chimeric antigen receptors that trigger phagocytosis
M. A. Morrissey, A. P. Williamson, A. M. Steinbach, E. W. Roberts, N. Kern, M. B. Headley, R. D. Vale
Abstract
Chimeric antigen receptors (CARs) are synthetic receptors that reprogram T cells to kill cancer. The success of CAR-T cell therapies highlights the promise of programmed immunity, and suggests that applying CAR strategies to other immune cell lineages may be beneficial. Here, we engineered a family of Chimeric Antigen Receptors for Phagocytosis (CAR-Ps) that direct macrophages to engulf specific targets, including cancer cells. CAR-Ps consist of an extracellular antibody fragment, which can be modified to direct CAR-P activity towards specific antigens. By screening a panel of engulfment receptor intracellular domains, we found that the cytosolic domains from Megf10 and FcR{gamma} robustly triggered engulfment independently of their native extracellular domain. We show that CAR-Ps drive specific engulfment of antigen-coated synthetic particles and whole cancer cells. Addition of a tandem PI3K recruitment domain increased cancer cell engulfment. Finally, we show that CAR-P expressing macrophages reduce cancer cell number in co-culture by over 40%.\n\nSummaryWe report the first Chimeric Antigen Receptors for Phagocytosis (CAR-Ps) that promote engulfment of antigen-coated particles and cancer cells.
02 /Specification & Classification
Click any tag to browse matching papers- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CAR-MACROPHAGES ACTIVATE ANTI TUMOR T CELLS IN THE ABSENCE OF PHAGOCYTOSIS
Lea C. Feldmann, Amaury Vaysse, … Capucine L. Grandjean·bioRxiv·Aug 28, 2026
- An in situ generated CAR-M with IFNg and negative dominance Sirpa isoform augments hepatocellular carcinoma immunotherapy
Xiang Li, Jing Hu, … Panpan Zhang·Journal of NanobiotechnologyPeer-reviewed·May 26, 2026
- CD47 suppresses phagocytosis by repositioning SIRPA and preventing integrin activation
M. A. Morrissey, R. D. Vale·bioRxiv·Aug 30, 2019
- CSPG4-targeting CAR-macrophages inhibit melanoma growth
Daniel Greiner, Qian Xue, … Minna Roh‐Johnson·OncogenePeer-reviewed·Mar 13, 2025
- Induced Pluripotent Stem Cell-derived CAR-Macrophage Cells with Antigen-dependent Anti-Cancer Cell Functions for Liquid and Solid Tumors
- Targeting macrophages with CAR-T cells delays solid tumor progression and enhances anti-tumor immunity
A. R. Sanchez-Paulete, J. Mateus-Tique, … B. D. Brown·bioRxiv·Dec 17, 2021